Results showed that mice receiving the Spirulina-derived EVs adjuvanted vaccine had over 100 times increased production of antibodies.
Vaccine
Researchers have modified a common probiotic bacteria to develop a nasal vaccine that can help us fight influenza’s seasonal infection.
Scientists have recently developed adaptable “train model” vaccines targeting SARS-CoV-2 variants, showing promising animal trial results with robust antibody responses and reduced viral loads, aiming for broad, long-lasting protection.
To combat virus-led diabetes progression, could virus-like particles be the next step?”
Future pandemics might be prevented using a safe, non-invasive nasal spray.
To prevent rabies spillover to humans, scientists look into developing a transmissible vaccine for bats using a herpes virus.
micro-bites.org 